封面
市场调查报告书
商品编码
1358130

DNA/基因微阵列市场:按类型、按用途、按最终用户、按地区

DNA/Gene Microarray Market, By Type,By Application,By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 163 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2023 年,全球 DNA/基因微阵列市场将达到 42.4 亿美元,预测期内(2023-2030 年)年复合成长率为 12.9%。

报告范围 报告详情
基准年 2022年 2023年市场规模 42.4亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 12.90% 2030年市场规模预测 99.1亿美元
2023 年按类型分類的 DNA/基因微阵列的全球市场占有率(%)
DNA/基因微阵列市场-IMG1

DNA 晶片、生物晶片或 DNA 微阵列由玻璃、硅片或尼龙膜等材料製成的显微镜玻片结构,其上印有数千个微观斑点。已知的 DNA 序列和基因规律地排列在这些点上。 DNA微阵列利用核酸杂交的原理,DNA微阵列的类型包括cDNA微阵列、寡聚DNA微阵列、BAC微阵列和SNP微阵列。 DNA 晶片的用途包括转录组和蛋白质组研究、疾病诊断和微生物鉴定。 DNA 微阵列或晶片是一种半导体表面,其上附着有多种基因的序列和探针。 DNA 微阵列用于对基因组的不同区域进行基因分型并同时评估多个基因的表达量。此方法可应用于临床诊断、农业和环境管理等领域。

市场动态

DNA/基因微阵列结合了生物资料和统计专业知识,为各种生物系统提供了新的观点。 DNA/基因微阵列检测样本中基因 (mRNA) 转录物的水平,并可将数千个基因片段放置在阵列上,从而提供癌症中基因表现的全基因组视图。因此,癌症患病的增加预计将在预测期内推动市场成长。例如,根据全球癌症罹患率和死亡率资料库Globocan 发布的一份报告,2021 年 2 月,2020 年全球报告了 1,930 万新癌症病例。女性乳癌已超过肺癌成为最常见的癌症,预计 2020 年全球整体新增病例将达 230 万例,其次是肺癌、大肠癌、摄护腺癌和胃肠癌。

此外,根据美国美国癌症诊断人数为 1,603,844 人,癌症死亡人数为 602,347 人。

本研究的主要特点

  • 该研究报告对全球DNA/基因微阵列市场进行了详细分析,并提供了以2022年为基准年的预测期(2023-2030)的市场规模和年复合成长率(CAGR) 。它揭示了各个细分市场的潜在收入机会,并说明了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数,介绍了全球 DNA/基因微阵列市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、类型经营团队、市场扩张和行销策略做出资讯的决策。
  • 全球 DNA/基因微阵列市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
  • 透过用于分析全球 DNA/基因微阵列市场的各种策略矩阵,将有助于相关人员做出决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第3章市场动态、法规及趋势分析

    • 市场动态
  • 促进因素
  • 抑制因素
  • 市场机会
    • 影响分析
    • 合併、收购和合作
    • 法规场景
    • 主要进展
    • PEST分析
    • 波特的分析
    • 技术进步
    • 製造商收入

第4章全球 DNA/基因微阵列市场,COVID-19 的影响分析

    • 经济影响
    • 新型冠状病毒(COVID-19)的流行病学
    • 对需求和供给的影响

第5章全球 DNA/基因微阵列市场,依类型,2018-2030 年

  • 寡核苷酸DNA微阵列
  • 互补DNA微阵列

第6章全球 DNA/基因微阵列市场,依用途,2018-2030

  • 基因组学
  • 蛋白质体学
  • 农业生物学
  • 环境
  • 医药研发
  • 癌症/肿瘤学
  • 其他(SNP分析等)

第7章全球 DNA/基因微阵列市场,依最终用户划分,2018-2030 年

  • 生物製药和製药公司
  • 诊断实验室
  • 研究机构
  • 其他(学术机构等)

第8章全球 DNA/基因微阵列市场(按地区),2018-2030 年

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • 公司简介
    • Affymetrix, Inc.
    • Illumina, Inc.
    • Agilent Technologies Inc.
    • Roche NimbleGen Inc.
    • Sequenom, Inc.
    • Biometrix Technology Inc.
    • LC Sciences
    • Life Technologies Corp.
    • Lifegen Technologies LLC
    • Microarrays Inc.
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Caliper Life Sciences
    • Perkin Elmer, Inc.
    • PathogenDx, Inc.
    • Twist Bioscience Corporation
    • Arraylt Corporation
    • Molecular Device, LLC
    • Raybiotech Inc.

第10章章

  • 参考
  • 调查方法
简介目录
Product Code: CMI3825

The global DNA/gene microarray market is estimated to be valued at US$ 4.24 Billion in 2023 and is expected to exhibit a CAGR of 12.9% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 4.24 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 12.90% 2030 Value Projection: US$ 9.91 Bn
Global DNA/Gene Microarray Market Share (%), By Type, 2023
DNA/Gene Microarray Market - IMG1

DNA chips, biochips, or DNA microarrays consist of a microscope slide made of materials such as glass, silicon chips, and nylon membrane, which is printed with thousands of minute spots. These spots contain a known DNA sequence or gene in an ordered sequence. DNA microarrays use the nucleic acid hybridization principle, and types of DNA microarrays include cDNA microarrays, oligo DNA microarrays, BAC microarrays, and SNP microarrays. Applications of DNA chips include the study of transcriptomes and proteomes, the diagnosis of diseases, the identification of microbes, and others. A DNA microarray or chip is a semiconductor surface on which sequences of many varied genes are bonded to probes. DNA microarrays are used to genotype different areas of a genome or to assess the expression levels of several genes at once. The method is applicable to areas such as clinical diagnostics, agriculture, environmental management, and other fields.

Market Dynamics

The field of cancer research has made the most extensive use of DNA/gene microarrays, which combine biological data with statistical expertise to provide fresh perspectives on a variety of biological systems. A DNA/gene microarray, therefore, measures the levels of gene (mRNA) transcripts in a sample, and since thousands of gene fragments can be located on an array, it can provide a genome-wide view of gene expression in cancer. Thus, the increasing prevalence of cancer is expected to fuel market growth over the forecast period. For instance, in February 2021, according to the report published by Globocan, a worldwide database of cancer incidence and mortality rates, 19.3 million new cancer cases were reported worldwide in 2020. Female breast cancer had surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases globally in 2020, followed by lung, colorectal, prostate, and stomach cancers.

Furthermore, according to the Centers for Disease Control and Prevention, there were 1,603,844 new cancer cases and 602,347 people who died of cancer in the U.S. in 2020.

Key features of the study:

  • This report provides an in-depth analysis of the global DNA/gene microarray market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global DNA/gene microarray market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Caliper Life Sciences, Perkin Elmer, Inc., PathogenDx, Inc., Twist Bioscience Corporation, Arraylt Corporation, Molecular Device, LLC and Raybiotech Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global DNA/gene microarray market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global DNA/gene microarray market.

Detailed Segmentation:

  • Global DNA/Gene Microarray Market, By Type:
    • Oligonucleotide DNA Microarrays
    • Complementary DNA Microarrays
  • Global DNA/Gene Microarray Market, By Application:
    • Genomics
    • Proteomics
    • Agricultural Biology
    • Environment
    • Drug Research and Development
    • Cancer/oncology
    • Others (SNP Analysis, etc.)
  • Global DNA/Gene Microarray Market, By End User:
    • Biopharmaceutical and Pharmaceutical Companies
    • Diagnostic Laboratories
    • Research Laboratories
    • Others (Academic Institutes, etc.)
  • Global DNA/Gene Microarray Market, By Region:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles
    • Affymetrix, Inc.
    • Illumina, Inc.
    • Agilent Technologies Inc.
    • Roche NimbleGen Inc.
    • Sequenom, Inc.
    • Biometrix Technology Inc.
    • LC Sciences
    • Life Technologies Corp.
    • Lifegen Technologies LLC
    • Microarrays Inc.
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Caliper Life Sciences
    • Perkin Elmer, Inc.
    • PathogenDx, Inc.
    • Twist Bioscience Corporation
    • Arraylt Corporation
    • Molecular Device, LLC
    • Raybiotech Inc.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
    • PORTER'S Analysis
    • Technological Advancements
    • Manufacturer Revenue

4. Global DNA/Gene Microarray Market - COVID-19 Impact Analysis

    • Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand

5. Global DNA/Gene Microarray Market, By Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oligonucleotide DNA Microarrays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Complementary DNA Microarrays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

6. Global DNA/Gene Microarray Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Proteomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Agricultural Biology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Environment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Drug Research and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Cancer/Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Others (SNP Analysis, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

7. Global DNA/Gene Microarray Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Biopharmaceutical and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Research Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others(Academic Institutes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global DNA/Gene Microarray Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast, Y-o-Y Growth and By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/ Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • Affymetrix, Inc.
    • Illumina, Inc.
    • Agilent Technologies Inc.
    • Roche NimbleGen Inc.
    • Sequenom, Inc.
    • Biometrix Technology Inc.
    • LC Sciences
    • Life Technologies Corp.
    • Lifegen Technologies LLC
    • Microarrays Inc.
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • Caliper Life Sciences
    • Perkin Elmer, Inc.
    • PathogenDx, Inc.
    • Twist Bioscience Corporation
    • Arraylt Corporation
    • Molecular Device, LLC
    • Raybiotech Inc.

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact